ASHKADIA LUH ZAHRA, NIM. 2021050007 (2025) STUDI IN SILICO POTENSI TANAMAN CENGKEH (Syzygium aromaticum) PADA PENGOBATAN DIABETES MELITUS TIPE 2. Skripsi thesis, UNIVERSITAS MUHAMMADIYAH GOMBONG.
|
Text
ASHKADIA LUH ZAHRA NIM. 2021050007.pdf Download (1MB) |
Abstract
Background: Type 2 diabetes mellitus (DM type 2) is a metabolic disease whose prevalence is increasing globally and is one of the leading causes of death worldwide. Treatment of type 2 diabetes generally uses synthetic oral therapy, but long-term use often causes side effects. The clove plant (Syzygium aromaticum) is known to contain secondary metabolite compounds that have the potential to be natural anti-diabetic agents. Purpose: This study aims to determine the potential of active compounds from clove plants as therapeutic agents of type 2 DM through the mechanism of interaction with target proteins, namely Dipeptidyl Peptidase-4 (DPP-4) and PPARγ Protein. Method: The research was conducted in silico using the molecular docking method using AutoDockTools software. The test compounds were selected based on the criteria of druglikeness, pharmacokinetics, and toxicity. The comparative compounds used are sitagliptin and natural ligands. Statistical analysis was carried out using the ANOVA test. Results: The results of the screening of clove plant compounds were obtained six compounds that met the requirements, namely 2-Heptanone, 5-Hydroxytryptamine, Kaempferol, Rhamnocitrin, Rhamnetin, 5-Methoxytryptamine. The docking results were obtained compounds bound to 5T4B protein with the lowest affinity binding, namely Rhamnetin -7.93 kcal/mol, while compounds bound to 5Y2O protein with the lowest affinity binding were Rhamnocitrin -7.19 kcal/mol, beta-Caryophyllene 6.38 kcal/mol, and centellin -5.66 kcal/mol. Conclusion: Based on the results, the secondary metabolite compound of the clove plant that has the best potential as an anti-Diabetes Mellitus type 2 is Rhamnetin with the strongest interaction that occurs to form a hydrogen bond. Recommendation: Experimental tests in vitro and in vivo are required to confirm the therapeutic potential of the compound.
| Item Type: | Thesis (Skripsi) |
|---|---|
| Additional Information: | Dr. apt. Muhammad Husnul Khuluq, M.Farm; Sugeng Supriyanto, M.S.Farm |
| Uncontrolled Keywords: | anti-DM tipe 2; in silico; molecular docking; clove plants; tanaman cengkeh |
| Subjects: | S1 Farmasi |
| Divisions: | Prodi Farmasi S1 |
| Depositing User: | Desy Setiyawati - |
| Date Deposited: | 16 Nov 2026 07:10 |
| Last Modified: | 16 Nov 2026 07:10 |
| URI: | http://repository.unimugo.ac.id/id/eprint/4595 |
Actions (login required)
![]() |
View Item |
